As the COVID-19 pandemic hit, emergency rooms and doctor’s offices were left empty. The number of Telehealth visits began to soar and amid changes in regulation and perception by patients, telehealth was now seen as a viable and thriving option.
In part one of this three-part series, Peter Urbanowicz and Karen Davis from A&M's Healthcare Industry Group are joined by Dr. David Shulkin, former Secretary of the United States Department of Veterans Affairs and Senior Advisor of A&M's Healthcare Industry Group and Dr. Lewis Levy, Chief Medical Officer of Teladoc. In this podcast they'll discuss the dramatic increase in telehealth usage since the COVID-19 crisis began, the strategies that providers and other organizations have been imploring and implementing, and what the future of telehealth looks like in a constantly changing healthcare environment.
Please contact Peter or Karen if you would like to have a conversation.
Peter Urbanowicz
Managing Director and Co-Head of Healthcare Industry Group
purbanowicz@alvarezandmarsal.com
+1 214 662 7389
Karen Davis
Managing Director, Healthcare Industry Group
kdavis@alvarezandmarsal.com
+1 205 223 6823
For other podcasts in this series:
Part II – Addressing Necessary Regulatory and Compliance Risk
Part III - The Future of Telehealth
Access Reimagined: Meeting Evolving Workforce Expectations While Expanding Patient Reach
April 23, 2026
Redesign the system. Realign incentives. Reimagine access. Patrick J. Byrne, M.D., Chief of Cleveland Clinic's Integrated Surgical, and Lisa Ishii, M.D., M.H.S, SVP of Operations for Johns Hopkins Health System join A&M Healthcare Industry Group's Brian Giessler to share their vision for redesigning healthcare to deliver the right care at the right time.
LS: Next Growth Curve
April 22, 2026
Developed markets are facing structural headwinds, such as affordability constraints, pricing reform, as demographic saturation and slower volume growth are limiting expansion and resulting a moderating growth rate. In contrast, emerging markets are entering a phase of healthcare formalization and access expansion driven by rising chronic disease burden and government prioritization of pharmaceuticals
The Next Growth Curve: How Biopharma Can Win in Developing Markets
April 20, 2026
Developed markets are facing structural headwinds, such as affordability constraints, pricing reform, as demographic saturation and slower volume growth are limiting expansion and resulting a moderating growth rate. In contrast, emerging markets are entering a phase of healthcare formalization and access expansion driven by rising chronic disease burden and government prioritization of pharmaceuticals
Episode 1: Chris Ellis, Co-founder and CEO, Thatch
April 2, 2026
This podcast series presents conversations with Healthcare Leaders on strategies shaping health plan transformation, today.
